ArticleJournal of experimental & clinical cancer research : CR2025

WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.

Minglei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.